SEC Form D private-offering filing

RECODE THERAPEUTICS, INC.

Name: RECODE THERAPEUTICS, INC. - new SEC Form D private-offering filing, Menlo Park, CA
Published: 2025-10-23

A new SEC Form D private-offering notice from Menlo Park, CA, a $29,441,931 filer-stated offering target in Biotech. The source filing is one click away.

RECODE THERAPEUTICS, INC. site↗ Verified via SEC Form D

Clinical stage genetic medicines company developing inhaled mRNA based therapeutics using its SORT lipid nanoparticle delivery platform for respiratory diseases such as primary ciliary dyskinesia and cystic fibrosis.

Filed 2025-10-23Filed to raise $29,441,931First money in 2025-09-23Raised so far $29,441,931HQ (as filed) Menlo Park, CASector Biotech ✓Stage (inferred) GrowthCall status Debt-only offering

Source linked the Form D on EDGAR↗Website verified recodetx.com↗Named in the filing 12 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.